AR
Arvinas, Inc.
ARVN · NASDAQ
$9.39 +0.86% (+$0.08)
1M +4.45%
Market Cap $605.9M
P/E Ratio 65.15x
Div. Yield -
ROE 1.91%
Piotroski F-Score Moderate
6/9Valuation
27 /100
Expensive P/S 1.91x
P/E 65.15x
P/B 1.08x
Growth
78 /100
Growing Book val. growth 8.43%
Rev. growth 25.96%
FCF growth N/A
Profitability
25 /100
Weak Op. margin 4.45%
Gross margin 96.43%
FCF margin 65.93%
Quality
10 /100
Poor ROA 1.38%
ROIC 2.18%
Asset turnover 0.47x
Debt
100 /100
Low Net debt/EBITDA -29.76x
Debt/Equity 0.01x
Current ratio 7.91x
Stability
17 /100
Unstable EPS volatility 46.61%
Beta 1.74x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ARVN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Randy Teel
Employees
246
Headquarters
New Haven
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report